students walk on University of Idaho campus

Visit UI

Learn about the many reasons the University of Idaho could be a perfect fit for you. Schedule Your Visit

Parents on campus during orientation

Homecoming Sept. 25-Oct. 1

Join other Vandal families for a week of celebration and Vandal traditions. View Calendar

campus full of students

UI Retirees Association

UIRA has a membership of nearly 500 from every part of the University. Learn More

Biosafety Form Instructions and Definitions

What is a Biosafety Form?

It is a document describing a Principal Investigator's (PI’s) activities: (cultivation, production, release of recombinant DNA genetically modified organisms; use, possession, storage, transfer of Select Agents and Toxins and other infectious agents including handling of materials and tissues with known infectious agents) with biological agents (bacteria, recombinant DNA, fungi, transgenic organisms, viruses, rickettsiae, chlamydiae, parasites, allergens, viroids, virions, prions and other potentially biohazardous material that can be harmful to humans, livestock, plants, or the environment or that have been genetically modified by recombinant DNA technology) at UI that, when approved by the UI Institutional Biosafety Committee (IBC), provides authorization to utilize designated material(s) for the specified activities.

See Definitions Below.

It must be completed by a UI-affiliated PI who currently has or plans to possess, store, work with or transfer infectious agents or biological material that requires a federal permit, recombinant DNA/RNA (rec-DNA); transgenic animals, microbes and plants; (planting of USDA deregulated items does not require IBC oversight), established human cell lines designated as BSL-2, all activities including agents and toxins on the Select Agents and Toxins list; and propagation of agents from materials known to contain risk group 2 (BSL-2) organisms. If postdoctoral fellows and visiting scholars plan to work with potentially biohazardous material, they must submit the Biosafety Form under the auspices of a UI-affiliated PI.

Per UI policy, work with biological agents must receive authorization from the UI IBC prior to receiving the material or beginning work. Federal regulations and guidelines necessitate that work with biological agents at institutions receiving federal funds have IBCs that oversee these projects. CDC/NIH, USDA

Contact the UI Biosafety Officer ( or 208-885-4054) or the Office of Research Assurances ( or 208-885-6162) for assistance.

IBC approval is valid for three years. At three years the Biosafety Form expires. Courtesy renewal notifications are sent but it is the responsibility of the PI to maintain approval by submitting a renewal prior to the expiration date. It is recommended that renewals be submitted at least one month in advance of the expiration date. See submittal deadline information. 

BSL1 & BSL2 facilities along with CDC certified facilities are reviewed annually. Facility reviews are provided by the BSO. Approval is provided by the IBC.

Upon request, the BSO will meet with the PI and lab personnel to help prepare or update the BSM. BSMs are reviewed by the BSO. Approval is provided by the IBC.

There are a number of guidelines available to assist in determining biosafety levels for containment purposes. Use the references below when determining appropriate containment practices. The CDC guidelines are generally appropriate for work with infectious agents. The NIH guidelines refer primarily to work with recombinant DNA. The ISB guidelines are for plant containment information. The USDA guidelines apply to primarily plant and invertebrate work.

Use the following resources to help determine the risk group of biological agents:

Use the following references to help determine which E. coli strains are considered to be K12 or K12 derivatives:

Prior to beginning work with biological agents, the PI must ensure that all individuals involved with this work are appropriately trained and ensure that they have read and are following appropriate practices and procedures.

A PI whose activities involve any of the select agents (other than excluded agents) or toxins (greater than permissible toxin level) require registration with CDC or APHIS in order for facilities and investigators to be approved.


American Biosafety Association

These are levels deemed appropriate to the biological materials and activities as demonstrated by outside standard references including but not limited to Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH) and United States Department of Agriculture (USDA)/Animal and Plant Health Inspection Service (APHIS). In the event that this information is limited or inconclusive a full risk assessment should be performed. The IBC has the final authority to set appropriate biosafety levels.

Any bacteria, recombinant DNA, fungi, transgenic organisms, viruses, rickettsiae, chlamydiae, parasites, allergens, viroids, virions and prions that can be harmful to humans, livestock, plants or the environment or that have been genetically modified.

Biosafety in Microbiological and Biomedical Laboratories

Biosafety Level “X”

Institutional Biosafety Committee

Information Systems for Biotechnology

National Institutes of Health

Office of Biotechnology Activities

Infectious proteinaceous particles associated with transmissible spongiform encephalopathies in animals and humans.

Recombinant DNA Advisory Committee

According to NIH Section I-B,  

  1. molecules that are constructed outside living cells by joining natural or synthetic DNA segments to DNA molecules that can replicate in a living cell, or 
  2. molecules that result from the replication of those described in (i) above.

Agents listed in the Code of Federal Regulations (including, but not limited to, 42 CFR Part 73, 7 CFR Part 331 and 9 CFR Part 121) and are capable, if released, of generating a serious public health crisis or are high-consequence livestock pathogens. Storage, use and transfer of Select Agents & Toxins is limited and controlled by the National Centers for Disease Control and Prevention (CDC).

Office of Research Assurances

Physical Address:

Morrill Hall Room 209
Moscow, ID  83844

Mailing Address:
875 Perimeter Dr., MS 3010
Moscow, ID  83844-3010


Phone: 208-885-6162

Web: ORA Website